Free Account Opening + AMC Free Demat
Loading...

Aeroflex Industries IPO vs Concord Biotech IPO

Comparision between Aeroflex Industries IPO and Concord Biotech IPO.

IPO Details

Aeroflex Industries IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Concord Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Aeroflex Industries IPO is up to ₹351.00 Cr whereas the issue size of the Concord Biotech IPO is up to ₹1,551.00 Cr. The final issue price of Aeroflex Industries IPO is ₹108.00 per share and of Concord Biotech IPO is ₹741.00 per share.

  Aeroflex Industries IPO Concord Biotech IPO
Face Value ₹2 per share ₹1 per share
Issue Price (Lower) ₹102.00 per share ₹705.00 per share
Issue Price (Upper) ₹108.00 per share ₹741.00 per share
Issue Price (Final) ₹108.00 per share ₹741.00 per share
Discount (Retail)
Discount (Employee) ₹70.00 per share
Market Lot Size 130 shares 20 shares
Fresh Issue Size 1,50,00,000 shares
Fresh Issue Size (Amount) up to ₹162.00 Cr
OFS Issue Size 1,75,00,000 shares 2,09,25,652 shares
OFS Issue Size (Amount) up to ₹189.00 Cr up to ₹1,551.00 Cr
Issue Size Total 3,25,00,000 shares 2,09,25,652 shares
Issue Size Total (Amount) up to ₹351.00 Cr up to ₹1,551.00 Cr

IPO Timetable

Aeroflex Industries IPO opens on Aug 22, 2023, while Concord Biotech IPO opens on Aug 04, 2023. The closing date of Aeroflex Industries IPO and Concord Biotech IPO is Aug 24, 2023, and Aug 08, 2023, respectively.

  Aeroflex Industries IPO Concord Biotech IPO
Anchor Bid Date Aug 21, 2023 Aug 03, 2023
Issue Open Aug 22, 2023 Aug 04, 2023
Issue Close Aug 24, 2023 Aug 08, 2023
Basis Of Allotment (Tentative) Aug 29, 2023 Aug 11, 2023
Initiation of Refunds (Tentative) Aug 30, 2023 Aug 14, 2023
Credit of Share (Tentative) Aug 31, 2023 Aug 17, 2023
Listing date (Tentative) Aug 31, 2023 Aug 18, 2023
Anchor Lockin End date 1 Sep 28, 2023 Sep 10, 2023
Anchor Lockin End date 2 Nov 27, 2023 Nov 09, 2023

Financials

Aeroflex Industries IPO P/E ratio is 40.91, as compared to Concord Biotech IPO P/E ratio of 32.29.

  Aeroflex Industries IPO Concord Biotech IPO
Financial
Aeroflex Industries IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 202031 Mar 202131 Mar 202231 Mar 2023
Assets157.19161.64183.44213.98
Revenue144.94144.84240.99269.48
Profit After Tax4.696.0127.5130.15
Net Worth52.7058.7286.22114.09
Reserves and Surplus
Total Borrowing63.4653.0739.1345.01
Amount in ₹ Crore
Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets1,182.551,312.801,513.98
Revenue630.75736.35888.48
Profit After Tax234.89174.93240.08
Net Worth999.371,103.221,290.00
Reserves and Surplus
Total Borrowing86.3560.5931.24
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 91.09% 44.08%
Promoter Shareholding (Post-Issue) 66.99% 44.08%
P/E Ratio 40.91 32.29
Market Cap ₹7752.06 Cr.
ROE 26.43%% 20.06%%
ROCE 31.96%% 24.27%%
Debt/Equity 0.39
EPS ₹2.64 ₹20.79
RoNW 26.43%% 20%%

Shares Offered

In the Aeroflex Industries IPO retail investors (RII) are offered 1,15,08,824 shares while in Concord Biotech IPO retail investors are offered 1,15,08,824 shares. Qualified institutional buyers (QIB) are offered 62,76,490 shares in Aeroflex Industries IPO and 41,83,130 shares in Concord Biotech IPO.

  Aeroflex Industries IPO Concord Biotech IPO
Anchor Investor Reserveration 95,99,980 shares 62,74,695 shares
Market Maker Reserveration
QIB 62,76,490 shares 41,83,130 shares
NII 49,32,353 shares 31,37,348 shares
RII 1,15,08,824 shares 73,20,479 shares
Employee 0 shares 10,000 shares
Others
Total 2,32,17,667 shares 1,46,50,957 shares

Bids Received (Subscription)

Aeroflex Industries IPO subscribed 97.11x in total, whereas Concord Biotech IPO subscribed 24.87x.

  Aeroflex Industries IPO Concord Biotech IPO
QIB (times) 194.73x 67.67x
NII (times) 126.13x 16.99x
Big NII (times) 125.80x 19.30x
Small NII (times) 126.80x 12.37x
RII (times) 34.41x 3.78x
Employee (times) 24.48x
Other (times) 28.52x
Total (times) 97.11x 24.87x

Comments

Add a public comment...